Aster Capital Management (Difc) LTD Exact Sciences Corp Transaction History
Aster Capital Management (Difc) LTD
- $540 Billion
- Q1 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 2,637 shares of EXAS stock, worth $144,613. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,637
Previous 83
3077.11%
Holding current value
$144,613
Previous $4.66 Million
2580.53%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$978 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$967 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$686 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$662 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$363 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...